The OneOncology Annual Conference is being held November 11-13 in Nashville, Tennessee, and brings together practice leaders, physicians, and advanced practice providers to discuss the business of oncology and scientific advancements, explained Davey Daniel, MD, chief medical officer of OneOncology.
The OneOncology Annual Conference is being held November 11-13 in Nashville, Tennessee, and brings together practice leaders, physicians, and advanced practice providers to discuss the business of oncology and scientific advancements, explained Davey Daniel, MD, chief medical officer of OneOncology.
Transcript
How does the OneOncology annual conference serve the participating physicians?
We're really excited about our OneOncology annual conference that we're holding. We're bringing together practice leaders and physicians and even our APP [advanced practice provider] team members into Nashville to spend time together, but also to discuss changes in the business of oncology, along with the science that's advancing in different specialties.
We're spending about a day and a half on where breast cancer, lung cancer, leukemias are going in the near future. We’ve asked the speakers to spend a little time almost forecasting where they think we'll be in a couple of years. The business section is also very exciting. We're getting a lot of input from our practice leaders, but also we're lucky that Nashville is a huge mecca for health care innovation, and we're going to be tapping into some of that as well.
What current issues in oncology management are you hearing about from your member practices and how are you addressing these in the conference program?
There are a lot of headwinds in oncology, both from the increased challenges of value-based care and preparing for EOM, the Enhancing Oncology Model. But also, how do we deal with changes in the payer makeup? How are we going to address the challenges that PBMs [pharmacy benefit managers] face to our practice? We'll be spending a lot of time discussing those challenges.
But we're also going to be spending some time on things like precision medicine, how do we really address the large volume of information that's coming at physicians, and how, as a network, we can actually leverage our centralized resources to make it easier for doctors to perform, to take care of patients, which is really what we're all there for.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Prostate Cancer Studies Show Why Personalized Treatment, Trial Diversity Matter, Dorff Says
February 21st 2025Tanya B. Dorff, MD, medical oncologist and professor in City of Hope’s Department of Medical Oncology & Therapeutics Research, was a discussant for the TALAPRO-2 and STOPCAP trials at the opening session of ASCO GU.
Read More
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More